UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051757
Receipt number R000059069
Scientific Title Japanese registry of primary prevention implantable cardioverter defibrillator in heart failure patients
Date of disclosure of the study information 2023/12/01
Last modified on 2024/01/30 09:31:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japanese registry of primary prevention implantable cardioverter defibrillator in heart failure patients

Acronym

J-Prime ICD

Scientific Title

Japanese registry of primary prevention implantable cardioverter defibrillator in heart failure patients

Scientific Title:Acronym

J-Prime ICD

Region

Japan


Condition

Condition

Heart failure patients with primary prevention implantable cardioverter defibrillator

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study investigates pharmacological and non-pharmaceutical treatments for heart failure patients with an ICD implanted for exploring appropriate ICD indication.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between pharmacological and non-pharmacological treatments and incidence of arrhythmia

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Heart failure patients with primary prevention implantable cardioverter defibrillator

Key exclusion criteria

HCM, ARVC, Brugada/LQT/idiopathic VF

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name Morio
Middle name
Last name Shoda

Organization

Tokyo Women's Medical University

Division name

Department of Cardiology

Zip code

162-8666

Address

kawada-cho 8-1, shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

suzuki.atsushi@twmu.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Suzuki

Organization

Tokyo Women's Medical University

Division name

Department of Cardiology

Zip code

162-8666

Address

kawada-cho 8-1, shinjuku-ku, Tokyo

TEL

03-3353-8111

Homepage URL


Email

suzuki.atsushi@twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Women's Medical University

Address

kawada-cho 8-1, shinjuku-ku, Tokyo

Tel

03-3353-8111

Email

carp-info.bm@twmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2028 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective observational study


Management information

Registered date

2023 Year 07 Month 31 Day

Last modified on

2024 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059069


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name